US EditionThyrocare Q4FY25 Revenue Up 21 Percent YoY to Rs 187.2 Cr; PAT Rises 24 Percent to Rs 21.3 Cr
Summary by up18news.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Thyrocare Q4FY25 Revenue Up 21 Percent YoY to Rs 187.2 Cr; PAT Rises 24 Percent to Rs 21.3 Cr
Navi Mumbai (Maharashtra) [India], April 25: Thyrocare Technologies Limited (hereinafter referred to as “Thyrocare” NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, announces their results for the quarter ended March 31, 2025. For Q4FY25, the company reported revenue from operations of INR 187.2 crore, reflecting a 21% year-over-year (YoY) growth. Normalized EBITDA for the […] The post Thyrocare Q4FY25 Revenue Up 21 Percen…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
